Veterinary Trend Watch

This week’s totals for reported parasiticide purchases across all segments year to date through the week ending March 6, are ahead of 2020 results by an extremely robust +12.2% among the 32,000+ practices and shelter locations in the Animalytix Marketplace. The most significant YOY change in the market is the +49.7% growth in the canine combination flea and heartworm products (e.g. specifically Simparica Trio), as substitution continues to occurring at the expense of products from the canine flea and tick preventatives which are experiencing a decline softening decline of (-1.9%) YTD. Canine heartworm preventatives purchases moved ahead of 2020’s record strong sales for the same period, posting growth of +2.6%. Feline flea and heartworm preventatives are now ahead of last year at a robust +8.8% growth.

Among the leading “Bellwether” parasiticide market zones, Greenville, SC now leads with +32.0% growth in total parasiticide purchases followed by Philadelphia, PA at +31.8%. Among the lagging “Bellwether” zones is Los Angeles, CA at +1.9% versus the same YTD period in 2020 bringing all “Bellwether” parasiticide market zones into the positive YTD.

For the month ending February 25, 2023, aggregate YTD practice revenues are at +8.5% net growth versus YTD 2023 for the ~3,000 reporting practices. Period performance growth in unique patients(pets) is at (-0.4%). Unique client and invoice growth posted (-0.4%) and (-0.4%) growth respectively vs PYTD results.

Among the listed “Bellwether” market zones, Greenville, SC lead with +14.9% YTD revenue growth while unique patient growth was at +3.3%. Los Angeles, CA was notable among the laggard zones, finishing at +2.6% revenue growth and (-3.7%) growth in unique patients vs PYTD.